repaglinide has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, H; Li, J; Li, Q; Xue, Y | 1 |
| Abernethy, DR; Arya, V; Atkinson, AJ; Berglund, EG; Grillo, JA; Huang, SM; Lesko, LJ; Pang, KS; Reynolds, KS; Song, P; Sugiyama, Y; Vieira, Mde L; Wu, TC; Zhang, L; Zhao, P; Zheng, JH | 1 |
| Andersen, MP; Hatorp, V; Huang, WC; Marbury, TC; Nielsen, KK; Ruckle, JL; Strange, P | 1 |
1 trial(s) available for repaglinide and Kidney Diseases
| Article | Year |
|---|---|
Pharmacokinetics of repaglinide in subjects with renal impairment.
Topics: Adult; Analysis of Variance; Area Under Curve; Carbamates; Creatinine; Female; Gas Chromatography-Mass Spectrometry; Humans; Hypoglycemic Agents; Kidney Diseases; Male; Middle Aged; Piperidines; Protein Binding; Renal Dialysis; Severity of Illness Index | 2000 |
2 other study(ies) available for repaglinide and Kidney Diseases
| Article | Year |
|---|---|
Repaglinide inhibits cyclosporine A-induced renal tubular toxicity\
by affecting apoptosis and \
Bax\
and \
Bcl-2\
expression
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Carbamates; Cyclosporine; Hypoglycemic Agents; Kidney; Kidney Diseases; Kidney Tubules; Male; Piperidines; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley | 2018 |
Evaluation of exposure change of nonrenally eliminated drugs in patients with chronic kidney disease using physiologically based pharmacokinetic modeling and simulation.
Topics: Area Under Curve; Carbamates; Chronic Disease; Computer Simulation; Drug Interactions; Humans; Ketolides; Kidney Diseases; Models, Biological; Piperazines; Piperidines; Purines; Sildenafil Citrate; Sulfones | 2012 |